Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, and Strategic Profiles and Leading Reagent and Instrument Suppliers
This 225-page report presents a comprehensive analysis of the clinical significance and market needs for major transfusion diagnostic typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing innovative blood banking technologies and products.
More Publications
2015 Analysis of Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, and Strategic Profiles and Leading Suppliers
US$ 2,800.00
January 2015
225 pages
2015-2019 Emerging Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, and Strategic Profiles and Leading Suppliers
US$ 2,800.00
July 2015
225 pages
2017 Emerging Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, and Strategic Profiles and Leading Reagent and Instrument Suppliers
US$ 3,465.00
January 2017
225 pages
2016-2020 Emerging Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, and Strategic Profiles and Leading Reagent and Instrument Suppliers
US$ 3,080.00
March 2016
225 pages
2015 Analysis of Blood Typing, Grouping and NAT Screening Tests, and Strategic Profiles of Leading Suppliers
US$ 2,800.00
January 2015
225 pages
